Orphan designation: allogeneic peripheral blood mononuclear cells incubated in vitro with mitomycin C Treatment of in solid organ transplantation, 20/05/2026 Positive

Veterinary medicines European public assessment report (EPAR): Bexatil, Bexagliflozin, Status: Opinion

Clinical Trial Information System (CTIS) - Sponsor handbook

Highlights - European Medicines Agency (EMA) / European Chemicals Agency (ECHA) joint meeting with industry stakeholders

Horizon scanning: Identifying emerging trends

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - July 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 17 July 2026, 10:00 (CEST) to 17 July 2026, 11:30 (CEST)

PRAC: meeting archive 2018-2020

Human medicines European public assessment report (EPAR): Bimervax, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 30/03/2023, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Inhixa, enoxaparin sodium, Date of authorisation: 15/09/2016, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Vaxneuvance, pneumococcal polysaccharide conjugate vaccine (adsorbed), Date of authorisation: 13/12/2021, Revision: 9, Status: Authorised